January 24 2020 - FDA decision coming soon on Aimmune's contested peanut allergy drug
Flag link:
FDA decision nears on Aimmune's contested peanut allergy drug
FDA decision nears on Aimmune's contested peanut allergy drug
BioPharma Dive
FDA
Aimmune
peanut allergy
Palforzia
DBV Technologies
Viaskin Peanut
Flag link:
Where Will Intercept Pharmaceuticals Be in 5 Years?
Where Will Intercept Pharmaceuticals Be in 5 Years?
Motley Fool
Intercept Pharma
Ocaliva
Flag link:
Hey Sanofi, you need to freshen up your pipeline, perhaps with M&A: report
Hey Sanofi, you need to freshen up your pipeline, perhaps with M&A: report
Fierce Pharma
Sanofi
M&A
Gilead Sciences
Flag link:
Edwards Lifesciences stock takes a hit on TAVR report
Edwards Lifesciences stock takes a hit on TAVR report
Mass Device
devices
Edwards Lifesciences
TAVR
Flag link:
New Optical Biosensor Can Cut into Sepsis Diagnosis Time
New Optical Biosensor Can Cut into Sepsis Diagnosis Time
Medical Devices and Diagnostics Industry
devices
biosensors
sepsis
nanotechnology
Flag link:
PwC report sees pharma-biotech deals 'to be extremely active in 2020'
PwC report sees pharma-biotech deals 'to be extremely active in 2020'
Fierce Biotech
M&A
PwC
Flag link:
Upcoming events – Genmab's route to market, and late-stage data for Zogenix
Upcoming events – Genmab's route to market, and late-stage data for Zogenix
EP Vantage
Genmab
tisotumab vedotin
cervical cancer
Zogenix
Fintepla
Lennox-Gastaut Syndrome
Flag link:
Ipsen’s quick fix backfires
Ipsen’s quick fix backfires
EP Vantage
Ipsen
bone disease
palovarotene
Flag link:
Trifecta of sickle cell disease therapies extend life expectancy, but are not cost-effective — ICER
Trifecta of sickle cell disease therapies extend life expectancy, but are not cost-effective — ICER
Endpoints
ICER
sickle cell disease
Novartis
Adakveo
Global Blood Therapeutics
Oxbryta
Emmaus Life Sciences
Endari
Flag link:
Pfizer launches biosimilars to Roche’s ‘big three’ cancer drugs in US
Pfizer launches biosimilars to Roche’s ‘big three’ cancer drugs in US
Pharmaforum
Pfizer
Roche
biosimilars
Avastin
Zirabev
Herceptin
Trazimera
Rituxan
Ruxience
Flag link:
Roche's Tecentriq fails trial in form of urothelial cancer
Roche's Tecentriq fails trial in form of urothelial cancer
Reuters
Roche
Genentech
clinical trials
Tecentriq
urothelial cancer
bladder cancer
Flag link:
Current Pharma Reps wanted for Biologics Sales Rep
Flag link:
Neurology Account Specialist- Parkinson's
Flag link:
Neurology Account Specialist- Parkinson's
Flag link:
Neurology Account Specialist- Parkinson's
Flag link:
Neurology Account Specialist- Parkinson's
Flag link:
Neurology Account Specialist- Parkinson's
Flag link:
Neurology Account Specialist- Parkinson's
Flag link:
Neurology Account Specialist- Parkinson's
Flag link:

Pages